Table 1.
Authors and Year |
Test | Comparison RCC Subtype |
Imaging Criteria | Reported Results |
Characteristics of Tumors |
---|---|---|---|---|---|
Young et al 2013 [24] | CT | Clear cell | Threshold attenuation values in 3 phases |
84% accuracy (81/97) |
All sizes |
Wildberger et al 1997 [56] | CT | Clear cell | Qualitative features: solid, well-demarcated, central scar, spoke wheel pattern, hypodense after contrast |
12.2% (6/49) observations correct for oncocytoma |
All sizes |
Bird et al 2011 [57] | CT | All subtypes | Attenuation in 3 phases, % change |
p<0.05, using t-test for RCC v. oncocytoma |
< 4 cm, RCC group: 60% clear cell |
Davidson et al 1993 [58] | CT | All subtypes | Homogeneous enhancement and central sharply marginated scar |
No difference in small and large tumors, 33% called RCC |
All sizes |
Zhang et al 2007 [25] | CT | Clear cell | Qualitative features, enhancement in 2 phases |
No difference | All sizes, with small number oncocytoma |
Cornelias et al 2013 [67] | MRI | Clear cell | Segmental inversion post 5 min delay, and tumor-to-spleen signal intensity ratio |
55% sensitivity, 97% specificity, 86% PPV, 88% NPV |
All sizes |
Rosenkrantz et al 2010 [66] | MRI | Chromophobe | Qualitative features, segmental inversion post 3 min delay |
10% of chromophobe, oncocyctoma with segmental inversion |
All sizes, most < 4 cm |
Taouli et al 2009 [68] | MRI | All subtypes (solid tumors only) |
DWI in addition to contrast-enhanced MRI, ADC cutoff of <=1.66 × 10-3 mm2/sec (at b values 0, 400, 800) |
90% sensitivity, 83% specificity, AUC 0.854 for solid RCC |
All sizes >= 1 cm |